Short- and longer-term goals for change – A report from the 2nd workshops of the EHC Think Tank Workstreams on Registries, the Hub and Spoke Model and Patient Agency
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Bok A, Noone D, Skouw-Rasmussen; EHC Think Tank. Key challenges for patient registries – A report from the 1st workshop of the EHC Think Tank Workstream on Registries. J Haem Pract 2022; 9 (1): 14–19. doi: 10.2478/jhp-2022-0002.BokANooneDSkouw-RasmussenEHC Think TankKey challenges for patient registries – A report from the 1st workshop of the EHC Think Tank Workstream on Registries202291141910.2478/jhp-2022-0002Open DOISearch in Google Scholar
Bok A, Noone D, Skouw-Rasmussen; EHC Think Tank. Key challenges for hub and spoke models of care – A report from the 1st workshop of the EHC Think Tank on Hub and Spoke Treatment Models. J Haem Pract 2022; 9 (1): 20–26. doi: 10.2478/jhp-2022-0003.BokANooneDSkouw-RasmussenEHC Think TankKey challenges for hub and spoke models of care – A report from the 1st workshop of the EHC Think Tank on Hub and Spoke Treatment Models202291202610.2478/jhp-2022-0003Open DOISearch in Google Scholar
Bok A, Noone D, Skouw-Rasmussen; EHC Think Tank. Patient agency: key questions and challenges – A report from the 1st workshop of the EHC Think Tank Workstream on Patient Agency. J Haem Pract 2022; 9 (1): 27–35. doi: 10.2478/jhp-2022-0004.BokANooneDSkouw-RasmussenEHC Think TankPatient agency: key questions and challenges – A report from the 1st workshop of the EHC Think Tank Workstream on Patient Agency202291273510.2478/jhp-2022-0004Open DOISearch in Google Scholar
De Santis M, Hervas C, Weinman A, Bottarelli V. Patient empowerment – policy brief. RD Action, 2018. Available from http://www.rd-action.eu/wp-content/uploads/2018/09/PATIENT-EMPOWERMENT.pdf (accessed 13 October 2022).De SantisMHervasCWeinmanABottarelliVRD Action2018Available from http://www.rd-action.eu/wp-content/uploads/2018/09/PATIENT-EMPOWERMENT.pdf (accessed 13 October 2022).Search in Google Scholar
Ali SR, Bryce J, Tan LE, et al. The EuRRECa Project as a model for data access and governance policies for rare disease registries that collect clinical outcomes. Int J Environ Res Public Health 2020; 17(23): 8743. doi: 10.3390/ijerph17238743.AliSRBryceJTanLEThe EuRRECa Project as a model for data access and governance policies for rare disease registries that collect clinical outcomes20201723874310.3390/ijerph17238743Open DOISearch in Google Scholar
Richesson R, Vehik K. Patient registries: utility, validity and inference. Adv Exp Med Biol 2010; 686: 87–104. doi: 10.1007/978-90-481-9485-8_6.RichessonRVehikKPatient registries: utility, validity and inference20106868710410.1007/978-90-481-9485-8_6Open DOISearch in Google Scholar
Sernadela P, González-Castro L, Carta C, et al. Linked registries: connecting rare disease patient registries through a semantic web layer. Biomed Research Int 2017; 2017:8327980. doi: 10.1155/2017/8327980.SernadelaPGonzález-CastroLCartaCLinked registries: connecting rare disease patient registries through a semantic web layer201720178327980.10.1155/2017/8327980Open DOISearch in Google Scholar
Opladen T, Gleich F, Kozich V, et al. U-IMD: the first Unified European registry for inherited metabolic diseases. Orphanet J Rare Dis 2021; 16: 95 (2021). doi: 10.1186/s13023-021-01726-3.OpladenTGleichFKozichVU-IMD: the first Unified European registry for inherited metabolic diseases20211695202110.1186/s13023-021-01726-3Open DOISearch in Google Scholar
Ali SR, Bryce J, Smythe C, et al. Supporting international networks through platforms for standardised data collection – the European Registries for Rare Endocrine Conditions (EuRRECa) model. Endocrine 2021; 71(3): 555–560. doi: 10.1007/s12020-021-02617-0.AliSRBryceJSmytheCSupporting international networks through platforms for standardised data collection – the European Registries for Rare Endocrine Conditions (EuRRECa) model202171355556010.1007/s12020-021-02617-0Open DOISearch in Google Scholar
Kodra Y, Weinbach J, Posada-de-la-Paz M, et al. Recommendations for improving the quality of rare disease registries. Int J Environ Res Public Health 2018; 15(8): 1644. doi: 10.3390/ijerph15081644.KodraYWeinbachJPosada-de-la-PazMRecommendations for improving the quality of rare disease registries2018158164410.3390/ijerph15081644Open DOISearch in Google Scholar
Pipe S, Reddy KR, Chowdary P. Gene therapy: Practical aspects of implementation. Haemophilia 2022; 28 (Suppl 4): 44–52. doi: 10.1111/hae.14545.PipeSReddyKRChowdaryPGene therapy: Practical aspects of implementation202228Suppl 4445210.1111/hae.14545Open DOISearch in Google Scholar
Miesbach W, Chowdhary P, Coppens M, et al. Delivery of AAV-based gene therapy through haemophilia centres – A need for re-evaluation of infrastructure and comprehensive care: A joint publication of EAHAD and EHC. Haemophilia 2021; 27(6): 967–973. doi: 10.1111/hae.14420.MiesbachWChowdharyPCoppensMDelivery of AAV-based gene therapy through haemophilia centres – A need for re-evaluation of infrastructure and comprehensive care: A joint publication of EAHAD and EHC202127696797310.1111/hae.14420Open DOISearch in Google Scholar
Kaliyaperumal R, Wilkinson MD, Moreno PA, et al. Semantic modelling of common data elements for rare disease registries, and a prototype workflow for their deployment over registry data. J Biomed Semant 2022; 13: 9 (2022). doi: 10.1186/s13326-022-00264-6.KaliyaperumalRWilkinsonMDMorenoPASemantic modelling of common data elements for rare disease registries, and a prototype workflow for their deployment over registry data2022139202210.1186/s13326-022-00264-6Open DOISearch in Google Scholar
Health RI. Personal Health Train. Available from https://www.health-ri.nl/initiatives/personal-health-train (accessed 18 October 2022).HealthRIAvailable from https://www.health-ri.nl/initiatives/personal-health-train (accessed 18 October 2022).Search in Google Scholar
van Soest J, Sun C, Mussmann O, et al. Using the Personal Health Train for automated privacy-preserving analytics on vertically partitioned data. Stud Health Technol Inform 2018; 247: 581–585.van SoestJSunCMussmannOUsing the Personal Health Train for automated privacy-preserving analytics on vertically partitioned data2018247581585Search in Google Scholar
EAHAD. European Haemophilia Centres Certification. Available from https://eahad.org/european-haemophilia-centres-certification/ (accessed 18 October 2022).EAHADAvailable from https://eahad.org/european-haemophilia-centres-certification/ (accessed 18 October 2022).Search in Google Scholar
Maskrey N. Shared understanding with patients. JAMA Intern Med 2017; 177(9): 1247–1248. doi: 10.1001/jamainternmed.2017.1932.MaskreyNShared understanding with patients201717791247124810.1001/jamainternmed.2017.1932Open DOISearch in Google Scholar
Nossair F, Thornburg C. The role of patient and healthcare professional in the era of new hemophilia treatments in developed and developing countries. Ther Adv Hematol 2018; 9(8): 239–249. doi: 10.1177/2040620718784830.NossairFThornburgCThe role of patient and healthcare professional in the era of new hemophilia treatments in developed and developing countries20189823924910.1177/2040620718784830Open DOISearch in Google Scholar
Bahlman-can Ooijen W, van Belle E, Bank A, et al. Nursing leadership to facilitate patient participation in fundamental care: an ethnographic qualitative study. J Adv Nurs 2022; Jun 24. doi: 10.1111/jan.15329. Online ahead of print.Bahlman-can OoijenWvan BelleEBankANursing leadership to facilitate patient participation in fundamental care: an ethnographic qualitative study2022Jun2410.1111/jan.15329Online ahead of print.Open DOISearch in Google Scholar
Konkle BA, Coffin D, Pierce GF, et al. World Federation of Hemophilia Gene Therapy Registry. Haemophilia 2020; 26(4): 563–564. doi: 10.1111/hae.14015.KonkleBACoffinDPierceGFWorld Federation of Hemophilia Gene Therapy Registry202026456356410.1111/hae.14015Open DOISearch in Google Scholar
Konkle B, Pierce G, Coffin D, et al. Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH. J Thromb Haemost 2020; 18(11): 3074–3077. doi: 10.1111/jth.15023.KonkleBPierceGCoffinDCore data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH202018113074307710.1111/jth.15023Open DOISearch in Google Scholar
Konkle BA, Recht M, Hilger A, Marks P. The critical need for postmarketing surveillance in gene therapy for haemophilia. Haemophilia 2021; 27(Suppl 3): 126–131. doi: 10.1111/hae.13972.KonkleBARechtMHilgerAMarksPThe critical need for postmarketing surveillance in gene therapy for haemophilia202127Suppl 312613110.1111/hae.13972Open DOISearch in Google Scholar
Monaco L, Faccio L. Patient-driven search for rare disease therapies: the Fondazione Telethon success story and the strategy leading to Strimvelis. EMBO Mol Med 2017; 9(3): 289–292. doi: 10.15252/emmm.201607293.MonacoLFaccioLPatient-driven search for rare disease therapies: the Fondazione Telethon success story and the strategy leading to Strimvelis20179328929210.15252/emmm.201607293Open DOISearch in Google Scholar
EHC. Think Tank. Available from https://ehcthinktank.eu (accessed 6 January 2023).EHC. Think TankAvailable from https://ehcthinktank.eu (accessed 6 January 2023).Search in Google Scholar
Chatham House. Chatham House rule. Available from https://www.chathamhouse.org/about-us/chatham-house-rule (accessed 6 January 2023).Chatham HouseAvailable from https://www.chathamhouse.org/about-us/chatham-house-rule (accessed 6 January 2023).Search in Google Scholar